BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 9793394)

  • 1. [Expression of protein p53 in the adenoma-colorectal carcinoma sequence].
    Gafà R; Lanza G
    Pathologica; 1998 Aug; 90(4):351-6. PubMed ID: 9793394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenomas of the colon: overexpression of p53 protein and risk factors.
    Speroni AH; Vanzulli SI; Meiss RP
    Endoscopy; 1998 Sep; 30(7):623-6. PubMed ID: 9826142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 and bcl-2 protein expression in rectosigmoid adenomas.
    Papatheodoridis GV; Kapranos N; Tzouvala M; Triantafyllou K; Elemenoglou I; Karamanolis DG
    Am J Gastroenterol; 1998 Jul; 93(7):1136-40. PubMed ID: 9672345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P53 protein immunohistochemical expression in colonic adenomas with and without associated carcinoma.
    Saleh HA; Aburashed A; Bober P; Tabaczka P
    Am J Gastroenterol; 1998 Jun; 93(6):980-4. PubMed ID: 9647033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of bcl-2 and p53 in de novo and ex-adenoma colon carcinoma: a comparative immunohistochemical study.
    Mueller J; Mueller E; Hoepner I; Jütting J; Bethke B; Stolte M; Höfler H
    J Pathol; 1996 Nov; 180(3):259-65. PubMed ID: 8958802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A frequent alteration of p53 gene in carcinoma in adenoma of colon.
    Ohue M; Tomita N; Monden T; Fujita M; Fukunaga M; Takami K; Yana I; Ohnishi T; Enomoto T; Inoue M
    Cancer Res; 1994 Sep; 54(17):4798-804. PubMed ID: 8062281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical expression of fatty acid synthase, apoptotic-regulating genes, proliferating factors, and ras protein product in colorectal adenomas, carcinomas, and adjacent nonneoplastic mucosa.
    Visca P; Alò PL; Del Nonno F; Botti C; Trombetta G; Marandino F; Filippi S; Di Tondo U; Donnorso RP
    Clin Cancer Res; 1999 Dec; 5(12):4111-8. PubMed ID: 10632348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical analysis of p53 overexpression in human colonic tumors.
    Darmon E; Cleary KR; Wargovich MJ
    Cancer Detect Prev; 1994; 18(3):187-95. PubMed ID: 8076381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of cyclin E in human gastric adenomas and adenocarcinomas: correlation with proliferative activity and p53 status.
    Yasui W; Akama Y; Kuniyasu H; Yokozaki H; Semba S; Shimamoto F; Tahara E
    J Exp Ther Oncol; 1996 Mar; 1(2):88-94. PubMed ID: 9414392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
    J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The results of p53 immunostaining in colorectal adenomas, early cancers, advanced cancers and their hepatic metastasis].
    Saigusa N; Maruyama K; Sugimura H; Endoh Y; Baba S
    Gan To Kagaku Ryoho; 1996 Jun; 23 Suppl 2():159-63. PubMed ID: 8678561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 Protein overexpression in colorectal tumors from patients with familial adenomatous polyposis: is it an early or late event?
    Levi E; Stryker SJ; Rao MS
    Am J Gastroenterol; 1996 Jan; 91(1):11-4. PubMed ID: 8561108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of heterozygosity of p53 gene and p53 protein expression in human colorectal carcinomas.
    Campo E; de la Calle-Martin O; Miquel R; Palacin A; Romero M; Fabregat V; Vives J; Cardesa A; Yague J
    Cancer Res; 1991 Aug; 51(16):4436-42. PubMed ID: 1868464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression and significance of p53, c-erbB2, CEA proteins in colorectal adenoma and carcinoma].
    Shu M; Liu S; Yu P
    Hunan Yi Ke Da Xue Xue Bao; 1998; 23(2):129-32. PubMed ID: 10681823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of p53 and bcl-2 in colorectal adenomas and carcinomas].
    Sundblad AS; Chumbita RL; Zoppi JA
    Medicina (B Aires); 1997; 57(6):662-6. PubMed ID: 9674186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The significance of p53 gene mutations and expressions in human colorectal tumors].
    Qian H; Yu B; Zhou X
    Zhonghua Zhong Liu Za Zhi; 1995 Sep; 17(5):332-5. PubMed ID: 8697968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGF-beta 1 in colonic neoplasia. A genetic molecular and immunohistochemical study.
    Cardillo MR; Yap EP
    Arch Anat Cytol Pathol; 1996; 44(5-6):241-9. PubMed ID: 9339011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using a combination of cytochrome P450 1B1 and beta-catenin for early diagnosis and prevention of colorectal cancer.
    Chang H; Su JM; Huang CC; Liu LC; Tsai CH; Chou MC; Lin P
    Cancer Detect Prev; 2005; 29(6):562-9. PubMed ID: 16289386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bromodeoxyuridine uptake and proliferating cell nuclear antigen expression throughout the colorectal tumor sequence.
    Risio M; Candelaresi G; Rossini FP
    Cancer Epidemiol Biomarkers Prev; 1993; 2(4):363-7. PubMed ID: 8102291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent p53 gene mutations in serrated adenomas of the colorectum.
    Hiyama T; Yokozaki H; Shimamoto F; Haruma K; Yasui W; Kajiyama G; Tahara E
    J Pathol; 1998 Oct; 186(2):131-9. PubMed ID: 9924427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.